Low-density lipoprotein-mediated delivery of docosahexaenoic acid selectively kills murine liver cancer cells

Lacy Reynolds, Rohit S. Mulik, Xiaodong Wen, Archana Dilip, Ian R. Corbin

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Aim: The natural omega-3 polyunsaturated fatty acid, docosahexaenoic acid (DHA), has recently been credited for possessing anticancer properties. Herein, we investigate the cytotoxic actions of DHA-loaded low-density lipoprotein (LDL) nanoparticles in normal and liver cancer cells. Materials & methods: LDL-DHA nanoparticles were prepared and subjected to extensive biophysical characterization. The therapeutic utility of LDL-DHA nanoparticles was evaluated in normal and malignant murine hepatocyte cell lines, TIB-73 and TIB-75, respectively. Results & discussion: The engineered LDL-DHA nanoparticles possessed enhanced physical and oxidative stabilities over native LDL and free DHA. Dose-response studies showed that therapeutic doses of LDL-DHA nanoparticles that completely killed TIB-75 were innocuous to TIB-73. The selective induction of lipid peroxidation and reactive oxygen species in the cancer cells was shown to play a central role in LDL-DHA nanoparticle-mediated cytotoxicity. Conclusion: In summary, these findings indicate that LDL-DHA nanoparticles show great promise as a selective anticancer agent against hepatocellular carcinoma.

Original languageEnglish (US)
Pages (from-to)2123-2141
Number of pages19
JournalNanomedicine
Volume9
Issue number14
DOIs
StatePublished - Oct 1 2014

Fingerprint

Lipoproteins
Docosahexaenoic Acids
Liver Neoplasms
LDL Lipoproteins
Liver
cancer
Cells
Nanoparticles
Acids
acid
induction
Polyunsaturated fatty acids
Omega-3 Fatty Acids
Cytotoxicity
nanoparticle
Unsaturated Fatty Acids
Antineoplastic Agents
Lipids
Lipid Peroxidation
Hepatocytes

Keywords

  • Docosahexaenoic acid
  • Liver cancer
  • Low-density lipoprotein
  • Low-density lipoprotein receptor
  • Nanoparticle
  • Omega-3 fatty acids

ASJC Scopus subject areas

  • Materials Science(all)
  • Bioengineering
  • Biomedical Engineering
  • Medicine (miscellaneous)
  • Development

Cite this

Low-density lipoprotein-mediated delivery of docosahexaenoic acid selectively kills murine liver cancer cells. / Reynolds, Lacy; Mulik, Rohit S.; Wen, Xiaodong; Dilip, Archana; Corbin, Ian R.

In: Nanomedicine, Vol. 9, No. 14, 01.10.2014, p. 2123-2141.

Research output: Contribution to journalArticle

Reynolds, Lacy ; Mulik, Rohit S. ; Wen, Xiaodong ; Dilip, Archana ; Corbin, Ian R. / Low-density lipoprotein-mediated delivery of docosahexaenoic acid selectively kills murine liver cancer cells. In: Nanomedicine. 2014 ; Vol. 9, No. 14. pp. 2123-2141.
@article{2dc876bc0ff94530b028934b6c43d666,
title = "Low-density lipoprotein-mediated delivery of docosahexaenoic acid selectively kills murine liver cancer cells",
abstract = "Aim: The natural omega-3 polyunsaturated fatty acid, docosahexaenoic acid (DHA), has recently been credited for possessing anticancer properties. Herein, we investigate the cytotoxic actions of DHA-loaded low-density lipoprotein (LDL) nanoparticles in normal and liver cancer cells. Materials & methods: LDL-DHA nanoparticles were prepared and subjected to extensive biophysical characterization. The therapeutic utility of LDL-DHA nanoparticles was evaluated in normal and malignant murine hepatocyte cell lines, TIB-73 and TIB-75, respectively. Results & discussion: The engineered LDL-DHA nanoparticles possessed enhanced physical and oxidative stabilities over native LDL and free DHA. Dose-response studies showed that therapeutic doses of LDL-DHA nanoparticles that completely killed TIB-75 were innocuous to TIB-73. The selective induction of lipid peroxidation and reactive oxygen species in the cancer cells was shown to play a central role in LDL-DHA nanoparticle-mediated cytotoxicity. Conclusion: In summary, these findings indicate that LDL-DHA nanoparticles show great promise as a selective anticancer agent against hepatocellular carcinoma.",
keywords = "Docosahexaenoic acid, Liver cancer, Low-density lipoprotein, Low-density lipoprotein receptor, Nanoparticle, Omega-3 fatty acids",
author = "Lacy Reynolds and Mulik, {Rohit S.} and Xiaodong Wen and Archana Dilip and Corbin, {Ian R.}",
year = "2014",
month = "10",
day = "1",
doi = "10.2217/NNM.13.187",
language = "English (US)",
volume = "9",
pages = "2123--2141",
journal = "Nanomedicine",
issn = "1743-5889",
publisher = "Future Medicine Ltd.",
number = "14",

}

TY - JOUR

T1 - Low-density lipoprotein-mediated delivery of docosahexaenoic acid selectively kills murine liver cancer cells

AU - Reynolds, Lacy

AU - Mulik, Rohit S.

AU - Wen, Xiaodong

AU - Dilip, Archana

AU - Corbin, Ian R.

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Aim: The natural omega-3 polyunsaturated fatty acid, docosahexaenoic acid (DHA), has recently been credited for possessing anticancer properties. Herein, we investigate the cytotoxic actions of DHA-loaded low-density lipoprotein (LDL) nanoparticles in normal and liver cancer cells. Materials & methods: LDL-DHA nanoparticles were prepared and subjected to extensive biophysical characterization. The therapeutic utility of LDL-DHA nanoparticles was evaluated in normal and malignant murine hepatocyte cell lines, TIB-73 and TIB-75, respectively. Results & discussion: The engineered LDL-DHA nanoparticles possessed enhanced physical and oxidative stabilities over native LDL and free DHA. Dose-response studies showed that therapeutic doses of LDL-DHA nanoparticles that completely killed TIB-75 were innocuous to TIB-73. The selective induction of lipid peroxidation and reactive oxygen species in the cancer cells was shown to play a central role in LDL-DHA nanoparticle-mediated cytotoxicity. Conclusion: In summary, these findings indicate that LDL-DHA nanoparticles show great promise as a selective anticancer agent against hepatocellular carcinoma.

AB - Aim: The natural omega-3 polyunsaturated fatty acid, docosahexaenoic acid (DHA), has recently been credited for possessing anticancer properties. Herein, we investigate the cytotoxic actions of DHA-loaded low-density lipoprotein (LDL) nanoparticles in normal and liver cancer cells. Materials & methods: LDL-DHA nanoparticles were prepared and subjected to extensive biophysical characterization. The therapeutic utility of LDL-DHA nanoparticles was evaluated in normal and malignant murine hepatocyte cell lines, TIB-73 and TIB-75, respectively. Results & discussion: The engineered LDL-DHA nanoparticles possessed enhanced physical and oxidative stabilities over native LDL and free DHA. Dose-response studies showed that therapeutic doses of LDL-DHA nanoparticles that completely killed TIB-75 were innocuous to TIB-73. The selective induction of lipid peroxidation and reactive oxygen species in the cancer cells was shown to play a central role in LDL-DHA nanoparticle-mediated cytotoxicity. Conclusion: In summary, these findings indicate that LDL-DHA nanoparticles show great promise as a selective anticancer agent against hepatocellular carcinoma.

KW - Docosahexaenoic acid

KW - Liver cancer

KW - Low-density lipoprotein

KW - Low-density lipoprotein receptor

KW - Nanoparticle

KW - Omega-3 fatty acids

UR - http://www.scopus.com/inward/record.url?scp=84911480178&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84911480178&partnerID=8YFLogxK

U2 - 10.2217/NNM.13.187

DO - 10.2217/NNM.13.187

M3 - Article

C2 - 24397600

AN - SCOPUS:84911480178

VL - 9

SP - 2123

EP - 2141

JO - Nanomedicine

JF - Nanomedicine

SN - 1743-5889

IS - 14

ER -